Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Non-Muscle Invasive Bladder Neoplasms
×
durvalumab
×
Clear all
Filters
3
NCT03528694
2025-11-25
POTOMAC
AstraZeneca
Phase 3
Active not recruiting
1,018 enrolled